Toll-like receptor-4 antagonist (+)-naloxone elicits sexually dimorphic attenuation of inflammation-induced fetal programming in mice. Supplemental Tables 1-5
journal contribution
posted on 2019-06-21, 01:42 authored by Loretta Chin, Camilla Dorian, Mark HutchinsonMark Hutchinson, Sarah RobertsonSarah RobertsonSupplemental Tables S1-S5 from:
Toll-like receptor-4 antagonist (+)-naloxone elicits sexually dimorphic attenuation of inflammation-induced fetal programming in mice
Chin P-Y, Dorian C, Sharkey DJ, Hutchinson MR, Rice KC, Moldenhauer LM, Robertson SA.
Funding
NHMRC Project Grant APP1140916
History
Usage metrics
Keywords
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC